| Dishman Carbogen Amcis Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 540701 |
NSE Symbol : DCAL |
P/E(TTM) : 0.00 |
|
ISIN Demat : INE385W01011 |
Div & Yield% : 0.00 |
EPS(TTM) : 0.00 |
|
Book Value(₹) : 247.62 |
Market Cap(₹Cr) : 2,398.00 |
Face Value(₹) : 2.00 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|---|
| Gross Sales | 57.08 | 68.72 | 39.68 | 60.30 | 62.86 | 106.10 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 57.08 | 68.72 | 39.68 | 60.30 | 62.86 | 106.10 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 18.89 | 28.83 | 7.10 | 11.17 | 37.42 | 5.47 |
| Total Income | 75.97 | 97.55 | 46.78 | 71.47 | 100.28 | 111.57 |
| Total Expenditure | 70.59 | 67.74 | 43.18 | 55.89 | 59.43 | 85.57 |
| PBIDT | 5.38 | 29.81 | 3.60 | 15.58 | 40.85 | 26.00 |
| Interest | 21.71 | 22.14 | 23.51 | 20.61 | 20.26 | 21.31 |
| PBDT | -16.33 | 7.67 | -19.91 | -5.03 | 20.59 | 4.69 |
| Depreciation | 15.37 | 15.15 | 15.16 | 15.79 | 16.47 | 16.10 |
| Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -7.79 | -3.14 | -11.94 | -7.22 | 1.45 | -4.04 |
| Reported Profit After Tax | -23.91 | -4.34 | -23.13 | -13.60 | 2.67 | -7.37 |
| Extra-ordinary Items | -1.69 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | -22.22 | -4.34 | -23.13 | -13.60 | 2.67 | -7.37 |
| EPS (Unit Curr.) | -1.52 | -0.28 | -1.47 | -0.87 | 0.17 | -0.47 |
| EPS (Adj) (Unit Curr.) | -1.52 | -0.28 | -1.47 | -0.87 | 0.17 | -0.47 |
| Calculated EPS (Unit Curr.) | -1.52 | -0.28 | -1.48 | -0.87 | 0.17 | -0.47 |
| Calculated EPS (Adj) (Unit Curr.) | -1.52 | -0.28 | -1.48 | -0.87 | 0.17 | -0.47 |
| Calculated EPS (Ann.) (Unit Curr.) | -6.10 | -1.11 | -5.90 | -3.47 | 0.68 | -1.88 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | -6.10 | -1.11 | -5.90 | -3.47 | 0.68 | -1.88 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 31.36 | 31.36 | 31.36 | 31.36 | 31.36 | 31.36 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 9.43 | 43.38 | 9.07 | 25.84 | 64.99 | 24.51 |
| PBDTM(%) | -28.61 | 11.16 | -50.18 | -8.34 | 32.76 | 4.42 |
| PATM(%) | -41.89 | -6.32 | -58.29 | -22.55 | 4.25 | -6.95 |
